Skip to main content

DIT China Market Overview Healthcare & Life Sciences

29 Sep 2020
9:00 am - 10:00 am


China is open for business, this webinar will outline key policies, the market landscape and the opportunities in the healthcare and life sciences sector they create for UK businesses. DIT will outline the support we can offer to help you to take advantage of them.

Book online

The Market

China is the world’s second-largest healthcare market and continues to develop at double-digit rates. At £750billion it offers significant and growing commercial opportunities, including £90billon in pharma/biotech and £50billion med tech/diagnostics for 2019.


By 2020, China’s healthcare spending is expected to account for 6.5 to 7 percent of its total GDP, which is around £1.2 trillion. By 2030, China’s healthcare market is targeted to reach RMB 16 trillion (around £1.8 trillion). China offers the largest growth opportunity for all the emerging economies. China’s primary care market is therefore expected to grow from £42 billion in 2015 to £98 billion in 2020. Projections estimate 7000 clinics will open annual over the next ten years. At the heart of China’s health reform is the creation of a tiered system, based on general practitioners (GPs) and community health centres. China plans to train more than 300,000 general practitioners by 2030 to better cope with a national shortage, as released in its national healthcare strategy. For the healthcare sector in 2020-2021, DIT will focus our activity on the following clinical areas: respiratory (COPD), children and women’s health, diabetes and CVD.

Life Sciences

In 2019, China ranked as the second largest pharmaceutical market, growing from 9th in 2007. In 2018. US$43 billion of life sciences investment was raised for new venture capital and private equity funds.  China’s influence in life sciences has grown exponentially and now has numerous companies that serve the domestic market in providing greater access to medical products. For the life sciences sector in 2020-2021, DIT will focus on medical technology and the pharmaceutical industry, to bring more UK innovations to Chinese patients.

To Register for this Event

Audience: Open to companies in both healthcare and life sciences sectors with an interest to go to China.

For any further questions contact


Contact us